640 results on '"Mithieux, Gilles"'
Search Results
2. Intestinal gluconeogenesis controls the neonatal development of hypothalamic feeding circuits
3. Intestinal gluconeogenesis: A translator of nutritional information needed for glycemic and emotional balance
4. Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
5. Intestinal gluconeogenesis: metabolic benefits make sense in the light of evolution
6. Improvement of energy metabolism associated with NUTRIOSE® soluble fiber, a dietary ingredient exhibiting prebiotic properties, requires intestinal gluconeogenesis
7. A hypometabolic defense strategy against malaria
8. Intestinal gluconeogenesis shapes gut microbiota, fecal and urine metabolome in mice with gastric bypass surgery
9. Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia
10. The absence of hepatic glucose-6 phosphatase/ChREBP couple is incompatible with survival in mice
11. Adaptation of Hepatic, Renal, and Intestinal Gluconeogenesis During Food Deprivation
12. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
13. Pain sensing neurons promote tissue regeneration in adult mice
14. Driving regeneration, instead of healing, in adult mammals: the decisive role of resident macrophages through efferocytosis
15. mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease
16. Antiobesity effects of intestinal gluconeogenesis are mediated by the brown adipose tissue sympathetic nervous system.
17. Fish oil minimizes feed intake and improves insulin sensitivity in Zucker fa/fa rats
18. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia
19. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
20. Gut-Brain Glucose Signaling in Energy Homeostasis
21. Fish oil minimises feed intake and improves insulin sensitivity in Zucker fa/fa rats.
22. Contributors
23. Master role of glucose-6-phosphate in cell signaling and consequences of its deregulation in the liver and kidneys
24. Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia
25. A caveolin-1 dependent glucose-6-phosphatase trafficking contributes to hepatic glucose production
26. Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
27. Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
28. Insulin-like peptide 5 is a microbially regulated peptide that promotes hepatic glucose production
29. Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
30. A gut–brain neural circuit controlled by intestinal gluconeogenesis is crucial in metabolic health
31. Editorial: Human microbiota: A key player in the etiology and pathophysiology of cardiovascular and metabolic diseases
32. Intestinal gluconeogenesis: metabolic benefits make sense in the light of evolution
33. Crosstalk between gastrointestinal neurons and the brain in the control of food intake
34. A link between hepatic glucose production and peripheral energy metabolism via hepatokines
35. Adaptation of Hepatic, Renal and Intestinal Gluconeogenesis During Food Deprivation
36. La néoglucogenèse intestinale : une fonction insulinomimétique
37. Chronic intake of 4-Methylimidazole induces Hyperinsulinemia and Hypoglycaemia via Pancreatic Beta Cell Hyperplasia and Glucose Dyshomeostasis
38. Inflammation may prevent hepatocyte damage promoted by steatosis
39. The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice
40. Portal Glucose Infusion, Afferent Nerve Fibers, and Glucose and Insulin Tolerance of Insulin-Resistant Rats
41. The gut microbiota: stable bioreactor of variable composition?
42. Satiety and the role of μ-opioid receptors in the portal vein
43. Nutrient control of hunger by extrinsic gastrointestinal neurons
44. Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy
45. Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia
46. Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease
47. Transcription factor p63, a member of the p53 family of tumour suppressors, regulates hepatic glucose metabolism
48. Increased atherosclerosis in a mouse model of glycogen storage disease type 1a
49. Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy
50. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.